| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,237 |
1,117 |
$97K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,741 |
1,668 |
$96K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
699 |
648 |
$70K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
330 |
315 |
$36K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
713 |
695 |
$30K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
82 |
76 |
$26K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
421 |
342 |
$26K |
| 87631 |
|
116 |
96 |
$13K |
| 71045 |
Radiologic examination, chest; single view |
435 |
389 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,358 |
1,175 |
$8K |
| 87581 |
|
215 |
182 |
$5K |
| 87486 |
|
211 |
182 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
728 |
624 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
150 |
135 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
2,159 |
1,857 |
$4K |
| 70450 |
Computed tomography, head or brain; without contrast material |
39 |
37 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
246 |
222 |
$4K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
14 |
14 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
305 |
276 |
$4K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
1,914 |
1,300 |
$3K |
| 84703 |
|
542 |
471 |
$3K |
| 80053 |
Comprehensive metabolic panel |
295 |
256 |
$2K |
| 87081 |
|
294 |
268 |
$2K |
| 81001 |
|
727 |
621 |
$2K |
| 83690 |
|
342 |
298 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
380 |
362 |
$1K |
| J3490 |
Unclassified drugs |
363 |
214 |
$971.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
234 |
226 |
$890.20 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
78 |
76 |
$869.88 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
209 |
187 |
$864.48 |
| 80076 |
|
133 |
116 |
$851.87 |
| 83735 |
|
185 |
153 |
$735.26 |
| 70210 |
|
14 |
14 |
$728.39 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
38 |
26 |
$666.71 |
| 74018 |
|
20 |
18 |
$626.09 |
| 80061 |
Lipid panel |
59 |
55 |
$615.65 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
75 |
67 |
$535.45 |
| 80050 |
General health panel |
12 |
12 |
$474.72 |
| 86738 |
|
28 |
26 |
$354.06 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
19 |
17 |
$301.20 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
36 |
34 |
$231.40 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
49 |
47 |
$198.75 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
51 |
48 |
$191.12 |
| 86780 |
|
13 |
13 |
$182.04 |
| 84484 |
|
14 |
12 |
$131.07 |
| 86701 |
|
12 |
12 |
$109.12 |
| 81003 |
|
30 |
26 |
$65.49 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13 |
13 |
$57.57 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$51.31 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
14 |
$18.92 |
| J2704 |
Injection, propofol, 10 mg |
29 |
28 |
$4.43 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
73 |
44 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
215 |
182 |
$0.00 |